CIK 0001795091 · <br>Emerging growth company
OS Therapies Inc
Sign in to watch- Ticker
- OSTX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825118368
- Phone
- 410-297-7793
- Business address
- 15825 SHADY GROVE ROAD, SUITE 135, ROCKVILLE, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-22 | Galzahr Karim Director | Grant or award · Stock options (right to buy) | +50,000 | 50,000 | ||
| 2025-10-21 | Romness Paul A. President and CEO | Grant or award · Stock options (right to buy) | +1,000,000 | 1,000,000 | ||
| 2025-10-21 | Search Theodore F. Director | Grant or award · Stock options (right to buy) | +140,000 | 140,000 | ||
| 2025-10-21 | PETIT ROBERT See Remarks | Grant or award · Stock options (right to buy) | +500,000 | 500,000 | ||
| 2025-10-21 | Romness Paul A. President and CEO | Grant or award · Stock options (right to buy) | +1,950,000 | 1,950,000 | ||
| 2025-10-21 | Jarry Olivier Roger Director | Grant or award · Stock options (right to buy) | +140,000 | 140,000 | ||
| 2025-10-21 | Galzahr Karim Director | Grant or award · Stock options (right to buy) | +140,000 | 140,000 | ||
| 2025-10-21 | Ciccio John Director | Grant or award · Stock options (right to buy) | +140,000 | 140,000 | ||
| 2025-10-21 | Acevedo Christopher P. Chief Financial Officer | Grant or award · Stock options (right to buy) | +200,000 | 200,000 | ||
| 2025-10-21 | McKean-Dieser Avril Suzette Director | Grant or award · Stock options (right to buy) | +140,000 | 140,000 | ||
| 2025-05-07 | Auerbach Shalom 10% owner | Sale | −82,000 | $2.00 | $164K | 2,664,199 |
| 2025-04-10 | Auerbach Shalom 10% owner | Sale | −10,000 | $1.39 | $14K | 2,746,199 |
| 2025-04-09 | Auerbach Shalom 10% owner | Sale | −50,012 | $1.35 | $68K | 2,756,199 |
| 2025-02-28 | Romness Paul A. President and CEO | Other acquisition | +225,000 | 2,473,000 | ||
| 2025-02-27 | Auerbach Shalom 10% owner | Other disposition | −225,000 | $1.64 | $369K | 2,806,211 |
| 2025-02-14 | Auerbach Shalom 10% owner | Sale | −100,000 | $2.84 | $284K | 2,431,211 |
| 2025-01-15 | Auerbach Shalom 10% owner | Sale | −16,720 | $6.74 | $113K | 2,531,211 |
| 2024-08-02 | Auerbach Shalom 10% owner | Conversion | +23,371 | 23,371 | ||
| 2024-08-02 | Auerbach Shalom 10% owner | Conversion | +633,980 | 1,438,355 | ||
| 2024-08-02 | Auerbach Shalom 10% owner | Conversion | +27,486 | 1,465,841 |
Page 2 of 4 · 67 trades